FORM OF WARRANT BIONANO GENOMICS, INC.Purchase Agreement • March 2nd, 2020 • Bionano Genomics, Inc • Laboratory analytical instruments • New York
Bionano Genomics, Inc., a company organized under the laws of Delaware (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [HOLDER], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the six-month anniversary of the Issuance Date (the “Initial Exercisability Date”), but not after 5:00 p.m., New York time, on the Expiration Date, (as defined below), ______________ (_____________) fully paid non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this “Warr
WARRANTS AMENDMENT AND AGREEMENTWarrants Amendment and Agreement • March 2nd, 2020 • Bionano Genomics, Inc • Laboratory analytical instruments
This Warrants Amendment and Agreement (this “Agreement”), dated as of March 2, 2020, is by and between Bionano Genomics, Inc., a Delaware corporation (the “Company”), and the undersigned holders (collectively, the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”). Capitalized terms used and not otherwise defined herein have the meanings set forth in the Original Warrants (as defined below).
